Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2003
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003015902A3 High strength asymmetric cellulosic membrane
11/13/2003WO2003010183A3 Process for preparing variant polynucleotides
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003US20030212254 Use of an anion exchange resin (emp-7) as solid support for peptide synthesis and affinity chromatography
11/13/2003US20030212253 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema
11/13/2003US20030212248 Using low molecular weight thiol compound such as cysteine, cysteamine, glutathione and 2-mercaptoethanol to stabilze solutions comprised of folded proteins
11/13/2003US20030211977 Muscle relaxants; anticoagulants; cardiovascular disorders
11/13/2003US20030211973 Polyglutamic acid-camptothecin conjugates and methods of preparation
11/13/2003US20030211624 Screening mammary gland aspirates for tumor markers; tumor diagnosis
11/13/2003US20030211591 Separation of fibrinogen from plasma proteases
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211539 Apparatus for automated simultaneous chemical synthesis and optional purification of oligonucleotide and/or peptides on solid supports
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211487 High efficiency mapping of molecular variations to functional properties
11/13/2003US20030211471 Method for detecting ligands and targets in a mixture
11/13/2003US20030211465 Viricidal compound for prevention and treatment of human lymphadenopathy associated viral infection; immunotherapy
11/13/2003US20030211127 Controlled dissolution crosslinked prote in crystals
11/13/2003US20030211077 Stimulanting hematopoiesis
11/13/2003US20030209491 Immobilization; affinity separation of antibodies; medical diagnosis
11/13/2003CA2652991A1 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/13/2003CA2486224A1 Separation process and dyes for use therewith
11/13/2003CA2483552A1 Calicheamicin derivative-carrier conjugates
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1360490A1 Nucleic-acid programmable protein arrays
11/12/2003EP1360297A2 Ragweed allergens
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360282A2 Degradation and detection of tse infectivity
11/12/2003EP1360207A2 Protein arrays
11/12/2003EP1360193A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
11/12/2003EP1360192A1 A method for refolding of proteins
11/12/2003EP1196637A4 Peptide acceptor ligation methods
11/12/2003EP1117677B1 Ligand presenting assembly (lpa), method of preparation and uses thereof
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/12/2003EP0762928B1 Azlactone-functional membranes and methods of preparing and using same
11/12/2003CN1454994A Affinity chromatography method of separating and purifying single-component earthworm plasminogen
11/12/2003CN1454992A Algin lyase, and preparing method and use thereof
11/12/2003CN1454494A Albumen oligo peptide and preparing method thereof
11/12/2003CN1127515C Process for preparing certain AzA
11/12/2003CN1127514C Antineoplastic peptides
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2056279C Cell-free receptor binding assays, the production and use thereof
11/06/2003WO2003091720A1 Method of analyzing protein structure, protein structure analyzer, program and recording medium
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003027263A3 Proteins associated with cell growth, differentiation, and death
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002057792A3 Affinity selection-based screening of hydrophobic proteins
11/06/2003WO2002044143A9 Microcapillary arrays for high-throughput screening and separation of differently charged molecules using an electric field
11/06/2003WO2002034876A3 Protein data analysis
11/06/2003WO2000033865A8 Methods of inhibiting ectopic calcification
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208046 Pseudo native chemical ligation
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030208038 Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds
11/06/2003US20030207804 Peptide nucleic acids exhibit enhanced cellular uptake and distribution. The peptide nucleic acids of the invention comprise naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide
11/06/2003US20030207797 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207400 Double stranded DNA of target sequence(s) bound non-covalently to a sequence specific polyamide (SSP) moiety having a ligand moiety linked covalently to said polyamide; polyamide contains N-methylpyrrole or N-methylimidazole groups
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 518